TECH OFFER

Cancer Cell-Targeted Drug Composition

TECHNOLOGY OVERVIEW

The present invention relates to a cancer cell targeted drug composition comprising an anticancer compound of 1’ acetoxychavicol acetate encapsulated in a nanostructured lipid carrier derived from one or more lipids, a surfactant and a cancer cell specific ligand. The present invention relates to the use of the cancer cell targeted drug composition in the manufacture of a medicament for use in the prevention and treatment of cancer, the composition comprising a first component of a lipid carrier derived from one or more lipids, a surfactant and a cancer cell specific ligand of CXCR4 chemokine receptor antagonist, and a second component of an anticancer drug of 1’ acetoxyachavicol acetate present in an amount ranging from 0. 5% by weight to 7.5 % by weight of t he total lipid , wherein the second component is encapsulated in the first component.

Mega - Trends

Healthcare

Technology Readiness Level (TRL)

TRL 5

Patent Number

PI 2020005770

Get the technology fact sheet here:

Contact person for this offer:

ChM Dr. Lee Ching Shya, PhD (Dual), RTTP

Technology Transfer Manager

Email: leecs@um.edu.my

Tel: +603-7967-7351/ 013-2250151

MAKE AN ENQUIRY

press to zoom

press to zoom
1/1

MORE INFORMATION

You have a question to know about technologies or cooperations? 
Please Contact Us:

+603 - 7967 7351 / 013-2250151